公开(公告)号：US20170196888A1

公开(公告)日：2017-07-13

申请号：US15321281

申请日：2015-06-25

Applicant: Yeda Research and Development Co. Ltd.

Inventor： Yosef YARDEN ,  Mattia LAURIOLA

IPC: A61K31/573 ,  A61K9/00 ,  A61K31/517

CPC classification number: A61K31/573 ,  A61K9/0053 ,  A61K31/517 ,  A61K45/06 ,  A61K2300/00

Abstract: A method of treating cancer in a subject in need thereof is provided. The method comprising administering to the subject a receptor tyrosine kinase (RTK)-specific cancer therapy and a glucocorticoid or a glucocorticoid analog, such that an efficacy window of said RTK-specific cancer therapy and an efficacy window of said glucocorticoid or glucocorticoid analog substantially overlap.